Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.

Details

Serval ID
serval:BIB_87F4CD45B199
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.
Journal
Critical reviews in oncology/hematology
Author(s)
Alongi F., Arcangeli S., De Bari B., Giaj-Levra N., Fiorentino A., Mazzola R., Trovò M.
ISSN
1879-0461 (Electronic)
ISSN-L
1040-8428
Publication state
Published
Issued date
03/2017
Peer-reviewed
Oui
Volume
112
Pages
67-71
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
Small cell lung cancer (SCLC) is relative rare histology in lung cancer patients. The standard treatment, in patients with an intra-thoracic disease, is represented by the use of concurrent chemo-radiotherapy; while patients with early SCLC stage, surgical resection could be recommended. Stereotactic body radiotherapy (SBRT) is a recently introduced technique allowing the delivery of very high radiation doses to limited target volumes and it is considered the standard approach in the treatment of not operable stage I Non Small-Cell Lung Cancer (NSCLC). The successful role option of SBRT in early NSCLC in terms of local control and toxicity profile opened the issue in the use of this approach in early stage small cell lung cancer (SCLC). Aim of this review is to discuss the current literature in the safety and efficacy of SBRT in the treatment of patients with stage I SCLC.

Pubmed
Web of science
Create date
28/03/2017 16:43
Last modification date
20/08/2019 14:47
Usage data